MAPT and tauopathy: These convergent imaging and molecular findings support a link between repetitive blast exposure and early-stage tauopathy, and highlight the value of combined tau PET imaging and fluid biomarkers as non-invasive tools for early detection, monitoring, and targeted risk mitigation in blast-exposed populations.